Corporate Presentation August 6, 2026 Climb Bio Investor Presentation August 2026 R&D Spotlight Series May 5, 2026 Budoprutug and the CD19 Opportunity September 29, 2025 CLYM116 and the IgA Nephropathy (IgAN) Opportunity
